SI0891345T1 - Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof - Google Patents

Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof

Info

Publication number
SI0891345T1
SI0891345T1 SI9730222T SI9730222T SI0891345T1 SI 0891345 T1 SI0891345 T1 SI 0891345T1 SI 9730222 T SI9730222 T SI 9730222T SI 9730222 T SI9730222 T SI 9730222T SI 0891345 T1 SI0891345 T1 SI 0891345T1
Authority
SI
Slovenia
Prior art keywords
preparation
therapeutical uses
novel furan
diarylmethylidene
derivatives
Prior art date
Application number
SI9730222T
Other languages
English (en)
Slovenian (sl)
Inventor
Eric Nicolai
Jean-Marie Teulon
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of SI0891345T1 publication Critical patent/SI0891345T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI9730222T 1996-04-04 1997-04-03 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof SI0891345T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9604236A FR2747123B1 (fr) 1996-04-04 1996-04-04 Nouveaux derives diarylmethylidene tetrahydrofurane, leurs procedes de preparation, et leurs utilisations en therapeutique
FR9607922A FR2747124B1 (fr) 1996-04-04 1996-06-26 Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique
PCT/FR1997/000602 WO1997037984A1 (fr) 1996-04-04 1997-04-03 Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique
EP97919476A EP0891345B1 (fr) 1996-04-04 1997-04-03 Nouveaux derives diarylmethylidene furaniques, leurs procedes de preparation et leurs utilisations en therapeutique

Publications (1)

Publication Number Publication Date
SI0891345T1 true SI0891345T1 (en) 2002-02-28

Family

ID=9490907

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730222T SI0891345T1 (en) 1996-04-04 1997-04-03 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof

Country Status (28)

Country Link
EP (1) EP0891345B1 (es)
JP (1) JP2000508638A (es)
KR (1) KR20000005146A (es)
CN (1) CN1215396A (es)
AR (1) AR006539A1 (es)
AT (1) ATE204268T1 (es)
AU (1) AU717146B2 (es)
BG (1) BG62808B1 (es)
BR (1) BR9708510A (es)
CA (1) CA2248949A1 (es)
CZ (1) CZ318898A3 (es)
DE (1) DE69706157T2 (es)
DK (1) DK0891345T3 (es)
EE (1) EE03687B1 (es)
ES (1) ES2162678T3 (es)
FR (2) FR2747123B1 (es)
GE (1) GEP20032924B (es)
IL (1) IL126105A (es)
NO (1) NO984624L (es)
NZ (1) NZ331672A (es)
PL (1) PL329213A1 (es)
PT (1) PT891345E (es)
RU (1) RU2189979C2 (es)
SI (1) SI0891345T1 (es)
SK (1) SK283292B6 (es)
TW (1) TW353660B (es)
WO (1) WO1997037984A1 (es)
ZA (1) ZA972894B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180651B1 (en) * 1996-04-04 2001-01-30 Bristol-Myers Squibb Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics
JP2001518087A (ja) * 1997-04-02 2001-10-09 メルク フロスト カナダ アンド カンパニー 選択的シクロオキシゲナーゼ−2阻害薬としてのα−メチレン−γ−ラクトン類
FR2775477B1 (fr) * 1998-02-27 2000-05-19 Union Pharma Scient Appl Nouveaux derives diarylmethylene heterocycliques, leurs procedes de preparation et leurs utilisations en therapeutique
CN1106392C (zh) * 2000-10-24 2003-04-23 中国科学院上海有机化学研究所 一种β位不含取代基的丁烯酸内酯及其合成的方法
EP1562930A4 (en) * 2002-11-05 2008-12-10 Magnachem Int Lab Inc SYNTHETIC LACTONE FORMULATIONS AND METHOD OF USE
ATE515493T1 (de) * 2003-03-31 2011-07-15 Council Scient Ind Res Mercaptophenylnaphthylmethan-derivate und deren herstellung
PL1745791T3 (pl) 2003-05-07 2013-11-29 Osteologix As Leczenie chorób chrząstki/kości za pomocą rozpuszczalnych w wodzie soli strontu
US8779168B2 (en) * 2010-12-16 2014-07-15 Transitions Optical, Inc. Lactone compounds and materials made therefrom
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759432A1 (en) * 1993-01-15 1997-02-26 G.D. Searle & Co. Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a skin-related condition
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5585504A (en) * 1994-09-16 1996-12-17 Merck & Co., Inc. Process of making cox-2 inhibitors having a lactone bridge

Also Published As

Publication number Publication date
ES2162678T3 (es) 2002-01-01
SK283292B6 (sk) 2003-05-02
BG102771A (en) 1999-06-30
CN1215396A (zh) 1999-04-28
ZA972894B (en) 1997-11-04
NZ331672A (en) 2000-02-28
TW353660B (en) 1999-03-01
AU717146B2 (en) 2000-03-16
DK0891345T3 (da) 2001-12-03
EE9800333A (et) 1999-04-15
BR9708510A (pt) 1999-08-03
WO1997037984A1 (fr) 1997-10-16
AU2393397A (en) 1997-10-29
SK137598A3 (en) 1999-02-11
PL329213A1 (en) 1999-03-15
IL126105A0 (en) 1999-05-09
ATE204268T1 (de) 2001-09-15
EP0891345B1 (fr) 2001-08-16
FR2747123B1 (fr) 1998-06-26
NO984624L (no) 1998-11-30
CA2248949A1 (fr) 1997-10-16
EP0891345A1 (fr) 1999-01-20
FR2747123A1 (fr) 1997-10-10
GEP20032924B (en) 2003-03-25
FR2747124A1 (fr) 1997-10-10
RU2189979C2 (ru) 2002-09-27
EE03687B1 (et) 2002-04-15
BG62808B1 (bg) 2000-08-31
CZ318898A3 (cs) 1999-01-13
KR20000005146A (ko) 2000-01-25
NO984624D0 (no) 1998-10-02
DE69706157T2 (de) 2002-04-11
DE69706157D1 (de) 2001-09-20
FR2747124B1 (fr) 1998-06-26
AR006539A1 (es) 1999-09-08
IL126105A (en) 2001-08-26
PT891345E (pt) 2002-02-28
JP2000508638A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HU9503505D0 (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
HUP9601652A1 (en) Piridyl-naphthalene derivatives, process for the preparation thereof, and intermediates thereof
HUP0105480A3 (en) Benzofuran derivatives, process for preparation of the same and uses thereof
HUP9902576A3 (en) Novel erythromycin derivatives, method for preparing them, and use thereof as drugs
PL312270A1 (en) Novel derivatives of indolopiperidine, method of obtaining them and pharmaceutical preparation and method of obtaining same
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
AU1245495A (en) Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
AU3944397A (en) Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
HUP9901176A3 (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives and their intermediates
SI0891345T1 (en) Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
HUP9902311A3 (en) New triazolopurines, method of preparing them and their use as drugs
PL311838A1 (en) Novel derivatives of thienopyridone, method of obtaining them as well as pharmaceutical preparation and method of obtaining same
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
HUP9902925A3 (en) Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
HUP9701134A3 (en) New coumarin derivatives, processes for preparation thereof and their use intermediate for producing novel coumarin derivatives
HK1015763A1 (en) Benzoxazindione derivatives, process for their preparation and their use
HUP0001180A3 (en) Novel erythromycin derivatives, method for preparing them and their use as medicine
HUP0003857A3 (en) Method for preparing alkyloxy furanone-amine derivatives, compounds obtained by said method and use of said compounds
AU7847298A (en) Novel substituted 3H -benzoxazole-2-thiones and 3H -benzothiazole-2thi ones derivatives, method for preparing them and pharmaceutical comp ositions containing them
NZ323421A (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof
PL334134A1 (en) Novel derivatives of erythromycin, method of obtaining them and their application as drugs
AU8868498A (en) 1,3-oxazolinyl-biphenyl derivatives, preparation method and use as synthesis intermediates
AU4560597A (en) Novel diarylmethylene derivatives, method for preparing and therapeutic uses thereof
AU4706397A (en) Method for producing 1,8-diaminonaphthalines and their 2,3-dihydroperimidine derivatives